Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Vishay Precision Group
VPG
$1.12B
| $629K | ﹤0.01% |
38,184
+26,284
| +221% | +$430K |
|
|
DOM
2227
DELISTED
DOMINION RES BLACK WARRIOR TR
DOM
| $628K | ﹤0.01% |
+103,900
| New | +$805K |
|
|
VSR
2228
DELISTED
Versar, Inc.
VSR
| $627K | ﹤0.01% |
192,800
+300
| +0.2% | +$1.07K |
|
|
ASFI
2229
DELISTED
Asta Funding Inc
ASFI
| $625K | ﹤0.01% |
75,700
-9,900
| -12% | -$82.1K |
|
2230
Alpha Pro Tech
APT
$50.2M
| $624K | ﹤0.01% |
292,900
+35,200
| +14% | +$75.4K |
|
2231
Trex
TREX
$4.43B
| $623K | ﹤0.01% |
86,400
-1,139,216
| -93% | -$9.66M |
|
|
MRH
2232
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $623K | ﹤0.01% |
19,500
-5,291
| -21% | -$164K |
|
2233
HNI Corp
HNI
$3.09B
| $622K | ﹤0.01% |
15,900
-63,600
| -80% | -$2.32M |
|
|
STKL
2234
DELISTED
SunOpta
STKL
| $621K | ﹤0.01% |
44,100
-154,800
| -78% | -$1.92M |
|
|
LSG
2235
DELISTED
LAKE SHORE GOLD CORP
LSG
| $620K | ﹤0.01% |
+680,200
| New | +$526K |
|
|
ENVI
2236
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
| $620K | ﹤0.01% |
258,300
-2,744
| -1% | -$7.08K |
|
|
CTLP
2237
DELISTED
Cantaloupe
CTLP
| $618K | ﹤0.01% |
293,115
+72,900
| +33% | +$147K |
|
2238
TechTarget
TTGT
$330M
| $617K | ﹤0.01% |
69,900
+12,100
| +21% | +$88.9K |
|
2239
Kadant
KAI
$3.57B
| $615K | ﹤0.01% |
16,000
-19,608
| -55% | -$726K |
|
|
UAM
2240
DELISTED
Universal American Corp
UAM
| $614K | ﹤0.01% |
+73,700
| New | +$559K |
|
|
TEG
2241
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
| $612K | ﹤0.01% |
+8,597
| New | +$517K |
|
2242
Evercore
EVR
$12.1B
| $611K | ﹤0.01% |
10,600
-138,940
| -93% | -$7.62M |
|
2243
Shore Bancshares
SHBI
$819M
| $610K | ﹤0.01% |
67,686
+6,550
| +11% | +$61.2K |
|
|
ITI
2244
DELISTED
Iteris, Inc.
ITI
| $609K | ﹤0.01% |
358,100
+34,300
| +11% | +$63.1K |
|
|
SNBC
2245
DELISTED
Sun Bancorp Inc
SNBC
| $609K | ﹤0.01% |
30,360
+2,680
| +10% | +$51.4K |
|
|
VII
2246
DELISTED
Vicon Industries, Inc.
VII
| $608K | ﹤0.01% |
241,300
| – | – |
|
|
OSIR
2247
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $608K | ﹤0.01% |
+38,907
| New | +$572K |
|
2248
Old Second Bancorp
OSBC
$1.3B
| $607K | ﹤0.01% |
122,144
-20,467
| -14% | -$98.2K |
|
2249
Danaos Corp
DAC
$2.56B
| $605K | ﹤0.01% |
7,350
+700
| +11% | +$60.5K |
|
2250
Enterprise Financial Services Corp
EFSC
$2.41B
| $604K | ﹤0.01% |
33,470
-13,740
| -29% | -$252K |
|
Similar funds
Renaissance Technologies's Q2 2014 Portfolio in Review
As of Q2 2014, Renaissance Technologies held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Renaissance Technologies added most to Pfizer in Q2 2014, an estimated $276M increase.
- Renaissance Technologies's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Renaissance Technologies fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Renaissance Technologies's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Renaissance Technologies opened 450 new positions and closed 492 in Q2 2014.
- Renaissance Technologies's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.